EODData

MEMBERSHIP REGISTER LOG IN

FRA, 1BT: Enlivex Therapeutics Ltd

05 Oct 2026
LAST:

0.3400

CHANGE:
 0.03		OPEN:
0.3400		HIGH:
0.3400		ASK:
0.0000		VOLUME:
0
CHG(%):
8.11		PREV:
0.3700		LOW:
0.3400		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Oct 260.34000.34000.34000.34000
02 Oct 260.37000.37000.37000.37000
01 Oct 260.43800.43800.43800.43800
30 Sep 260.41800.41800.41800.41800
29 Sep 260.44400.44400.44400.44400
28 Sep 260.51500.51500.51500.51500
25 Sep 260.52500.52500.52500.52500
24 Sep 260.55000.55000.55000.55000
23 Sep 260.56000.56000.56000.56000
22 Sep 260.59500.59500.59500.59500

PROFILE

Name:Enlivex Therapeutics Ltd
About:Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra (ENX-CL-02-002), which is in phase II clinical trial for the treatment of organ dysfunction and failure caused by sepsis; and Allocetra (ENX-CL-05-001), which is in phase I/II clinical trial to treat moderate knee osteoarthritis. The company also develops 0189-22-KMC, which is in phase I/II clinical trial to treat end-stage knee osteoarthritis; 0006-24-KMC, which is in phase I/II clinical trial for the treatment of Basal thumb osteoarthritis; and ENX-CL-06-001 to treat Psoriatic arthritis and is in phase I/II clinical trial. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Ness Ziona, Israel.
Sector:Healthcare
Industry:Biotechnology
Address:14 Einstein Street, Ness Ziona, Israel, 7403618
Website:https://www.enlivex.com
ISIN:IL0011319527

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:0.00 
Forward P/E:-0.95 
PEG Ratio:-0.95 
Price to Book:0.01 
Return on Assets:-0.01 
Return on Equity:1.26 
Shares:23.85M 
Market Cap:8.11M 

TECHNICAL INDICATORS

MA5:0.4018.2%
MA10:0.4839.9%
MA20:0.6385.8%
MA50:1.31286.2%
MA100:1.31284.9%
MA200:1.07215.4%
RSI14:12.73 
WPR14:-100.00 
MTM14:-0.46
ROC14:-0.58 
ATR:0.04 
Week High:0.5251.5%
Week Low:0.340.0%
Month High:0.94176.5%
Month Low:0.34215.4%
Year High:6.351,767.6%
Year Low:0.340.0%

RECENT SPLITS

Date Ratio
09 Jul 20261-15
06 Mar 20191-8
25 Sep 20171-5